Journal of Alzheimer’s Disease

Impact Factor


85-90, 24 issues

Latest issue

88:3 online 02 August 2022

Next issue

88:4 scheduled for September 2022

Back volumes

From volume 1, 1998

ISSN print


ISSN online


Aims & Scope

The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.

In Remembrance of Editor-in-Chief Mark A. Smith

In 2018, JAD celebrated its 20th anniversary (see details here).

In association with JAD, a number of book titles relating to Alzheimer's disease are published by IOS Press. These include the book that was published to commemorate the centennial in 2006 of Alois Alzheimer's discovery of what would become to be known as Alzheimer's disease, as well as the book series 'Advances in Alzheimer's Disease' (AIAD), which has an always increasing nmuber of titles. The forward-looking book in the AIAD series was published in July 2018 (to order click here) and the gut microbiome title in July 2022 (to order click here).

Editorial Board


George Perry, PhD
University of Texas at San Antonio
One UTSA Circle

San Antonio, Texas 78249
Tel: +1 210 458 4450
Fax:+1 210 458 4445
ORCID: 0000-0002-6547-0172

Managing Editor

Beth Kumar
Department of Pathology
Case Western Reserve University

2103 Cornell Road
Cleveland, Ohio 44106
Tel:+1 216 368 3671
Fax:+1 216 368 8964
ORCID: 0000-0002-6547-0172

Former Editor-in-Chief (2001–2010)

Mark A. Smith†, PhD

Regional Editors

Sergio Ferreira
Jianping Jia
Amos Korczyn
Ricardo Maccioni
Pravat Mandal
Colin Masters
Akihiko Nunomura
Xinglong Wang
Jing Zhang

Deputy Editors

Jesus Avila
Paula Moreira 

Massimo Tabaton
Xiongwei Zhu

Reviews Editor

Daniela Galimberti

Ethics Editor

Allyson Rosen

Prevention Editor

Dharma Singh Khalsa

Scientometrics Editor

Aaron A. Sorensen

Senior Editors

Benedict Albensi
Kaarin Anstey
Mark Bondi
Lilian Calderón-Garcidueñas
Jack de la Torre
M. Arfan Ikram
Jianping Jia
Yong Liu
David Loewenstein
Riccardo Maccioni
Ralph Martins
Jordi Matías-Guiu
Giulio Pasinetti
Cyrus Raji
Jagannatha Rao Kosagisharaf
Lan Tan
Jin-Tai Yu
Ling-Qiang Zhu

Associate Editors

Full list of the Associate Editors at:

Editorial Board

Full list of the Editorial Board at:

Author Guidelines


By submitting my article to this journal, I agree to the Author Copyright Agreement, the IOS Press Ethics Policy, and the IOS Press Privacy Policy.

Note: Corresponding authors from eligible institutions may be eligible to a waiver or discount on the fee; see here for more details.

See the full instructions to authors on the JAD website.

Abstracted/Indexed in

CAB Abstracts
Cabell's Guide or Directory
Chemical Abstracts Service (CAS)
CSA Biological Sciences
CSA Illumina
CSA Illustrata Natural Sciences
CSA Neurosciences Abstracts
e-psyche database
EBSCO Databases
EVISA - European Virtual Institute for Speciation Analysis
Index Medicus
OA @ PubMedCentral
Prous Science Integrity
SciVerse Scopus
Ulrich's Periodicals Directory
Web of Science: Biological Abstracts
Web of Science: BIOSIS Previews
Web of Science: Journal Citation Reports/Science Edition
Web of Science: Science Citation Index Expanded (SciSearch®)

Open Access

By default, articles published in the Journal of Alzheimer’s Disease are available only to institutions and individuals with access rights. However, the journal offers all authors the option to purchase open access publication for their article as part of the IOS Press Open Library. This means that the final published version will be freely available to anyone worldwide, indefinitely, under a Creative Commons license and without the need to purchase access to the article. This is also referred to as “gold” open access.

Gold open access pricing
Authors who choose gold open access publication will be subject to an article publication charge of € 1500 / US$ 1700 for publication under the CC BY-NC 4.0 license or € 2200 / US$ 2500 for publication under the CC BY 4.0 license. Pricing is exclusive of possible taxes. After an article is accepted for publication, the corresponding author will be informed regarding the open access option during the production stages, and will have the opportunity to purchase open access for their article. It could be that the open access fee of an article is waived completely due an institutional agreement IOS Press has with the corresponding authors' institution. Please check the institutional agreements page for details.

Green open access
Authors who do not make use of the gold open access option may still make their article freely available using self-archiving, also referred to as green open access. Authors may make their final accepted manuscript available for free download from their personal or institutional website or institutional archive. This model is free for the author.

PubMedCentral deposits
This journal deposits all open access articles in PubMedCentral (PMC) as part of the IOS Press Open Library. If an author chooses to publish their paper with open access then the publisher will deposit the article in PMC upon publication.

Social Media & Mailings – The Journal of Alzheimer's Disease (JAD) is on Facebook and Twitter, so be sure to follow us and be part of the conversation! JAD also issues regular newsletters; not signed up yet? You can do so here: Read the recent newsletter here.

Discover our fully open access Alzheimer's journal – Perhaps you are also interested in JAD's sister journal, the open access Journal of Alzheimer's Disease Reports? See the contents here, and click here to view the newsletter of JADR Volume 6 for content published in Q1 2022.

JAD 20th Anniversary – During 2018, JAD had its 20th anniversary and to mark this occasion an open access issue of the journal was published in Vol.62, Iss.3 (view here). To read our special commorative publication, click here (PDF). Read our anniversary year summary here!

Latest Articles

Discover the contents of the latest journal issue:

Peripheral Inflammatory Biomarkers of Alzheimer’s Disease
Yanping Guo, Jing Hao, Keke Guo, Qingcheng Yang

COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
Khalid Iqbal, Narjes Baazaoui

Secular Trends in Dementia Free Cognitive Function in Older Adults: A Systematic Review
Eugene Y.H. Tang, Blossom C.M. Stephan, Eduwin Pakpahan, Bijetri Biswas, Alisha Gupta, Andrea Fairley, Alessandro Bosco, Connor D. Richardson, Louise Robinson, Mario Siervo

Additions to Alpha-Sheet Based Hypotheses for the Cause of Alzheimer’s Disease
Elena T. Wright, Philip Serwer, Barbara Hunter

Astrocyte Dysregulation and Calcium Ion Imbalance May Link the Development of Osteoporosis and Alzheimer’s Disease
Chieh-Tsung Yen, Yi-Liang Tsai, Yuh-Feng Wang

JAD COVID-19 banner

JAD news signup banner

JAD twitter banner


AIAD9 book banner showing colorful MRI scan of the guest editor that appears on the cover

Sustainable Development Goals

This journal supports IOS Press' actions relating to the Sustainable Development Goals (SDGs) and commits to the Diversity and Inclusion Statement.

dark blue banner for JAD author geo data for SDGs

More information will be available in due course. Check the SDGs page for updates.